Literature DB >> 15032692

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

Olivier Harari1, James K Liao.   

Abstract

MHC class II molecules are expressed on the surface of antigen presenting cells and are loaded with peptides processed from the phagosomal compartment of these cells. Such complexes interact with the CD4 positive T lymphocyte receptor for antigen and a strong interaction is followed by T cell activation and proliferation. As class II expression is critical for antigen specific immunity its expression mostly restricted to a few cell types but can be induced on others in response to interferon gamma. This expansion of antigen presenting ability plays a role in increasing the duration and intensity of the immune response. Nitric oxide and antioxidants attenuate this class II induction through negative effects on the induction of class II transactivator protein expression and on the binding of transcription factor NF-Y to the class II promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032692      PMCID: PMC2633593          DOI: 10.2174/1381612043452893

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  64 in total

Review 1.  The bare lymphocyte syndrome and the regulation of MHC expression.

Authors:  W Reith; B Mach
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.

Authors:  J M Waldburger; K Masternak; A Muhlethaler-Mottet; J Villard; M Peretti; S Landmann; W Reith
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

Review 3.  Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology.

Authors:  K K Griendling; D Sorescu; B Lassègue; M Ushio-Fukai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

Review 4.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window.

Authors:  L Y Xu; J S Yang; H Link; B G Xiao
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes.

Authors:  N Ghosh; J F Piskurich; G Wright; K Hassani; J P Ting; K L Wright
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 8.  Cytokine and chemokine based control of HIV infection and replication.

Authors:  M Alfano; G Poli
Journal:  Curr Pharm Des       Date:  2001-07       Impact factor: 3.116

9.  Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.

Authors:  M L Kielar; S C Sicher; J G Penfield; D R Jeyarajah; C Y Lu
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

Review 10.  Immunology of VIP: a review and therapeutical perspectives.

Authors:  R P Gomariz; C Martinez; C Abad; J Leceta; M Delgado
Journal:  Curr Pharm Des       Date:  2001-01       Impact factor: 3.116

View more
  54 in total

1.  Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Authors:  Robert S Tacke; Hai-Chon Lee; Celeste Goh; Jeremy Courtney; Stephen J Polyak; Hugo R Rosen; Young S Hahn
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 2.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

3.  Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.

Authors:  Jessica L Rastad; William R Green
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

5.  Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.

Authors:  Jin Wu; Ruihua Zhang; Ning Tang; Zizhen Gong; Jiefei Zhou; Yingwei Chen; Kang Chen; Wei Cai
Journal:  J Leukoc Biol       Date:  2014-10-23       Impact factor: 4.962

6.  Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.

Authors:  Lalit Batra; Pradeep Shrestha; Hong Zhao; Kyle B Woodward; Alper Togay; Min Tan; Orlando Grimany-Nuno; Mohammad Tariq Malik; María M Coronel; Andrés J García; Haval Shirwan; Esma S Yolcu
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

Review 7.  COX-2 and PGE2-dependent immunomodulation in breast cancer.

Authors:  Edward P Chen; Emer M Smyth
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-31       Impact factor: 3.072

Review 8.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 9.  Myeloid-derived suppressor cells in B cell malignancies.

Authors:  Yaghoub Yazdani; Mousa Mohammadnia-Afrouzi; Mehdi Yousefi; Enayat Anvari; Ghasem Ghalamfarsa; Hadi Hasannia; Sanam Sadreddini; Farhad Jadidi-Niaragh
Journal:  Tumour Biol       Date:  2015-09-02

10.  Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia.

Authors:  Chen Zhang; Guang-Sheng Lei; Shoujin Shao; Hsin-Wei Jung; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2012-08-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.